Centre Georges François Leclerc - Oncologie Médicale

Dijon

0 studies enrolling now · 2 studies all time

What they study most

Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer, Head and Neck Cancer

Studies at this site

• Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) — Stopped early
• Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC — Stopped early